HIV in Podcast United States

Experiencias de personas latinas con el VIH en los Estados Unidos (Español)

Tue, 16 Dec 2025 16:09:36 +0000

Jose Rodriguez-Garcia, MD (Family Medicine Physician and HIV Specialist, Banner Health, Phoenix, Arizona, USA), y Duvia Lozano, LMSW (Program Director, Chicanos Por La Causa, LUCES, Phoenix, Arizona, USA) hablan sobre experiencias de personas latinas con el VIH en los Estados Unidos. Las notas del programa: HIV_in_Podcast_USA_Latine_Experiences_Spanish_Transcript.pdf

Latine Experiences with HIV in the USA (English)

Tue, 16 Dec 2025 16:09:21 +0000

Jose Rodriguez-Garcia, MD (Family Medicine Physician and HIV Specialist, Banner Health, Phoenix, Arizona, USA), and Duvia Lozano, LMSW (Program Director, Chicanos Por La Causa, LUCES, Phoenix, Arizona, USA), discuss their experiences of caring for Latine people living with HIV in the USA. Show notes: HIV_in_Podcast_USA_Latine_Experiences_English_Transcript.pdf

Broadening uptake of HIV PrEP: Considerations in key populations (Cisgender women, and Black and Hispanic/Latine men who have sex with men)

Tue, 19 Aug 2025 15:28:04 +0100

In this episode, Dr Tavell Kindall discusses the barriers to HIV PrEP use among key populations, specifically cisgender women and Black and Hispanic/Latine men who have sex with men. The views expressed are those of the speakers and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in May 2025, and the content reflects the information available at that time. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/PrEP_Uptake_Transcript.pdf

Understanding barriers to HIV PrEP use: Uptake and considerations to support adherence

Tue, 19 Aug 2025 15:27:52 +0100

In this episode, Dr June Gipson discusses the barriers to HIV PrEP use, highlighting various challenges that hinder PrEP adoption and adherence. The views expressed are those of the speakers and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in May 2025, and the content reflects the information available at that time. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/Barriers_to_PrEP_Transcript.pdf

Introduction to the HIV PrEP landscape: Potential impact, eligible populations, and an overview of the HIV PrEP care system

Tue, 19 Aug 2025 15:27:33 +0100

In this episode, Dr Yolanda Lawson provides an overview of the current HIV epidemic and PrEP landscape in the United States. The importance of education for healthcare providers and methods for addressing disparities PrEP usage are also discussed. The views expressed are those of the speakers and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in May 2025, and the content reflects the information available at that time. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/PrEP_Landscape_Transcript.pdf

Archive Resistance

Thu, 17 Jul 2025 20:47:41 +0100

Dr Michelle D’Antoni discusses archived HIV resistance and its impact on antiretroviral therapy. The views expressed are those of the speakers and not necessarily Gilead Sciences, Inc. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/Archive_Resistance_Transcript.pdf

Engagement in HIV care

Mon, 14 Jul 2025 16:04:53 +0100

Dr Megan Dunbar is joined by Dr Theo Hodge for a conversation about improving engagement in HIV care throughout the care pathway. The expert panel will discuss barriers to engagement and the available strategies, tools, and resources to increase engagement in HIV care. The views expressed by the expert panel are those of the panelists and not necessarily those of Gilead Sciences, Inc. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/Engagement_in_HIV_care_Transcript.pdf

History of the AIDS Epidemic Including HIV Drug Resistance

Fri, 04 Jul 2025 11:39:08 +0100

In this episode, Dr Joel Gallant gives a history of antiretroviral therapy and HIV drug resistance, drawing on his personal and professional experience beginning in the early 1980s. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/History_of_ART_and_Resistance_Transcript.pdf

Conversations on The Lived Experiences of Black Women with HIV - Part 2

Fri, 04 Jul 2025 11:15:03 +0100

Danielle Houston (former employee of Gilead Sciences) and Minka Carter (Gilead Sciences) discuss their experiences of caring for Black women living with HIV. Show notes: https://s3.eu-west-2.amazonaws.com/ox.files/BW_with_HIV_Transcript.pdf

Conversations on The Lived Experiences of Black Women with HIV - Part 1

Fri, 04 Jul 2025 11:14:53 +0100